Retailers
By Abigail Townsend
Date: Thursday 26 Feb 2026
(Sharecast News) - Veterinary chain CVS Group posted a fall in interim profits on Thursday amid higher costs and "challenging" market conditions in the UK.
| CVS Group upbeat on potential overhaul of Veteri... | 28-Jan-2026 | ShareCast |
| Director dealings: CVS, Odyssean non-execs incre... | 06-Jan-2026 | ShareCast |
| Transaction in Own Shares | 02-Jan-2026 | ShareCast |
| Total Voting Rights | 31-Dec-2025 | ShareCast |
| Transaction in Own Shares | 31-Dec-2025 | ShareCast |
| Total Voting Rights | 27-Feb-2026 | 07:00 | RNS |
| Form 8.3 - The Vanguard Group, Inc.: Picton Prop... | 12-Feb-2026 | 20:10 | EQS Group |
| Interim Results | 26-Feb-2026 | 07:00 | RNS |
| Total Voting Rights | 30-Jan-2026 | 07:00 | RNS |
| Standard form for notification of major holdings | 29-Jan-2026 | 14:02 | RNS |
| Vet chain’s £40m for acquisitions | 22-Dec-2011 | The Scotsman |
| Questor : CVS Group | 21-Oct-2010 | Telegraph |
| Questor:CVS Group | 06-Oct-2009 | Telegraph |
| Tempus:CVS Group | 23-Sep-2009 | Times |
| Oil sector begins recovery | 11-Oct-2007 | Guardian |
| Tempus: CVS Group | 11-Oct-2007 | Times |
No recent information was found.
| Currency | UK Pounds |
| Share Price | 1,328.00p |
| Change Today | 14.00p |
| % Change | 1.07 % |
| 52 Week High | 1,424.00 |
| 52 Week Low | 922.00 |
| Volume | 624,747 |
| Shares Issued | 70.16m |
| Market Cap | £931.68m |
| Beta | 0.00 |
| RiskGrade | 136 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 5 |
| Buy | 2 |
| Neutral | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 10 |

| Latest | Previous | |
|---|---|---|
| Final | Final | |
| Ex-Div | 06-Nov-25 | 31-Oct-24 |
| Paid | 05-Dec-25 | 29-Nov-24 |
| Amount | 8.50p | 8.00p |
| Time | Volume / Share Price |
| 16:39 | 33,116 @ 1,328.00p |
| 16:37 | 35,000 @ 1,326.97p |
| 15:59 | 115,000 @ 1,326.00p |
| 15:59 | 115,000 @ 1,326.00p |
| 16:35 | 5 @ 1,328.00p |
| CEO | Richard Fairman |
| Finance Director | Robin Alfonso |
You are here: research